Brief: Tenax Sees Cash, Cash Equivalents, Marketable Securities To Be Enough To Fund Ops Through Q2
31/03/2022 13:40
March 31 (Reuters) - Tenax Therapeutics Inc TENX.O :
* TENAX THERAPEUTICS REPORTS FISCAL YEAR 2021 RESULTS AND
PROVIDES
BUSINESS UPDATE
* TENAX THERAPEUTICS - EXPECTS CURRENT CASH, CASH
EQUIVALENTS AND
MARKETABLE SECURITIES WILL BE SUFFICIENT TO FUND CURRENT
OPERATIONS THROUGH Q2 2022
Source text for Eikon: ID:nBw6z2MRTa
Further company coverage: TENX.O
((Reuters.Briefs@thomsonreuters.com;))